The observation to females with hyperprolactinemia
The object of research. The stages of observation the pregnant females with different types of the hyperprolactinemia will invent for the lowering the risk of the abortion and the placental insufficiency. The Materials and methods of the research: 1a group - 20 pregnant females with microadenoma of hypophysis and regular treatment by bromocriptine.1b group - 20 pregnant females with microadenoma of hypophysis and irregular treatment by bromocriptine. 2-nd group- 20 pregnant females with hyperprolactinemia and hyperandrogenia. 3-th group- 30 pregnant females with hyperprolactinemia and autoimmunity pathology (hypothyroidism, dibetes mellitus). The clinical, laboratorial, instrumental and math's methods of the research were used. The results. The levels of prolactine in groups were differently: in 1-st group before starting the treatment - 4356±387.1 mME/l, with treatment- 657±54.3 mME/l; in 2-nd group 867±65.3 mME/l and 453±39.2 mME/l; in 3-th group - 934±96.2 mME/l and 376±34.5 mME/l correspondly (р<0.001). The progesterone's level of the pations with abortion was lower (43.4±3.35 nmol/l) than the level of the pations with development pregnancy (69.4±4.9 nmol/l) (р<0,05), so the preserving treatment was added by utrogestan. The conclusion. The stagical principle of the organization the treatment help for females with hyperprolactinemia helps to keep the reproductive function, to decrease the risk of the abortion and the placental insufficiency, to warn the postconfinements recidivations